/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.30%
Natural Gas
-4.81%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.39%
VIX
N/A
Economic Calendar
EUR/USD
-0.30%
Natural Gas
-4.81%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.39%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
China Trade Data Signals a Weaker Demand Outlook
22 minutes ago
Crude Inventories Declined By 4.6 Million Barrels
about 12 hours ago
ADP Reports Moderate Job Growth, Pay Increase in November
about 12 hours ago
JOLTs Job Openings Declined To 8.73 Million In October
1 day ago
PPI Up by 0.2% in Both Euro Area and the EU; In Line with Expectations
1 day ago
RBA Keeps the Cash Rate at 4.35% and Recognizes a Softer Inflation Trend
2 days ago
Crypto News Today: Dogecoin Strikes $0.1063 on 10th Anniversary
8 minutes ago
XRP News: Optimism Toward the SEC v Ripple Case Resurfaces
about 2 hours ago
AUD to USD Forecast: Australian Trade Surplus Widens on Export Rise
about 3 hours ago
USD/JPY Forecast: BoJ Pivot Chatter and US Jobless Claims in Focus
about 4 hours ago
Hang Seng Index, ASX 200, Nikkei 225: China Trade in the Spotlight
about 5 hours ago
Investors Speculate On Fed Rate Cuts Next Year, Possibly As Soon As March
about 5 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
BDSwiss Academy
ad
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
VTRS
profile
Viatris Inc
Follow
VTRS
(
Nasdaq - US
)
Closed
9.70
+0.09 (+0.88%)
in
:
usd
•
As of: Dec 06, 2023 15:59
UTC -5
Open
9.66
High
9.79
Low
9.63
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Dividends
About
Viatris Inc
CEO
Michael Goettler
Headquarters
1000 mylan boulevard
canonsburg, pa 15317, united states
Auditor
DELOITTE & TOUCHE LLP
Employees
37,000
Share Holders
108,736
Website
https://www.viatris.com/en
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Viatris Inc
Statistics
Valuation Measures
Market Capitalization
2
11.63B
Enterprise Value
30.35B
Enterprise Value/EBITDA
(ttm)
7.62
Price to Earnings Ratio
(ttm)
3.23
Price to Book
(mrq)
0.56
Price to Sales
(ttm)
0.75
Price to Cash
(ytd)
1.65
Profitability
Gross Margin
(ttm)
39.55%
Operating Margin
(ttm)
23.37%
Profit Margin
(ttm)
11.82%
Return on Equity
(ttm)
17.27%
Return on Invested Capital
(ttm)
4.53%
Return on Assets
(ttm)
7.35%
Income Statement
Revenue
(ttm)
15.47B
Revenue Per Share
(ttm)
12.89
Gross Profit
(ttm)
6.12B
EBITDA
(ttm)
3
3.99B
Net Income Avi to Common
(ttm)
1.83B
Diluted EPS
(ttm)
1.51
Share Statistics
Beta (5Y Monthly)
1.14
52-Week Change
-6.71%
S&P500 52-Week Change
15.43%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
1.20B
Dividend Yield
4.96%
Float
4
1.20B
%
Held by Insiders
0.26%
%
Held by Institutions
76.69%
Balance Sheet
Total Cash
(mrq)
1.31B
Total Cash Per Share
(mrq)
1.09
Total Debt
(mrq)
20.03B
Total Debt/Equity
(mrq)
96.00%
Current Ratio
(mrq)
1.60%
Quick Ratio
(mrq)
1.06%
Book Value Per Share
(mrq)
17.39
Cash Flow
Operating Cash Flow Per Share
(ytd)
1.92
Free Cash Flow
(ytd)
2.17B
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker